Antivirals for Virus Induced Exacerbations of Asthma and COPD Treatment

Antivirals for Virus Induced Exacerbations of Asthma and COPD Treatment

Viral respiratory infections in patients with asthma or chronic obstructive pulmonary disease (COPD) can cause severe exacerbations, increasing the risk of secondary bacterial infections and having a significant impact on disease-related morbidity and mortality. Several antivirals such as oseltamivi...

Full description

Bibliographic Details
Main Authors: Cristina Grigorescu, Antonela Antoniu Sabina, Ruxandra Oţelea Marina, Antohe Ileana, Petronela Fildan Ariadna, Anton Arghir Ioan, Doina Tofolean Ecaterina
Format: Article
Language:English
Published: Sciendo 2018-11-01
Series:ARS Medica Tomitana
Subjects:
antiviral therapy
asthma
copd
oseltamivir
zanamivir
Online Access:https://doi.org/10.2478/arsm-2018-0027
id doaj-aacdaa4950434c89b87d7e0d8bf54840
record_format Article
spelling doaj-aacdaa4950434c89b87d7e0d8bf548402021-09-06T19:41:19ZengSciendoARS Medica Tomitana1841-40362018-11-0124315215610.2478/arsm-2018-0027arsm-2018-0027Antivirals for Virus Induced Exacerbations of Asthma and COPD TreatmentCristina Grigorescu0Antonela Antoniu Sabina1Ruxandra Oţelea Marina2Antohe Ileana3Petronela Fildan Ariadna4Anton Arghir Ioan5Doina Tofolean Ecaterina6University of Medicine and Pharmacy “Gr. T. Popa”,Iasi, RomaniaUniversity of Medicine and Pharmacy “Gr. T. Popa”,Iasi, RomaniaUniversity of Medicine and Pharmacy “Carol Davila”, Bucharest, RomaniaUniversity of Medicine and Pharmacy “Gr. T. Popa”,Iasi, RomaniaFaculty of Medicine, University “Ovidius” of Constanta, RomaniaFaculty of Medicine, University “Ovidius” of Constanta, RomaniaFaculty of Medicine, University “Ovidius” of Constanta, RomaniaViral respiratory infections in patients with asthma or chronic obstructive pulmonary disease (COPD) can cause severe exacerbations, increasing the risk of secondary bacterial infections and having a significant impact on disease-related morbidity and mortality. Several antivirals such as oseltamivir and zanamivir evaluated in influenza and other virus-induced respiratory infections are discussed in this review as a starting point of their potential use in improving the outcome of asthma and COPD exacerbations. However, the efficacy of antiviral therapy for asthma/COPD exacerbations needs a further evaluation.https://doi.org/10.2478/arsm-2018-0027antiviral therapyasthmacopdoseltamivirzanamivir
collection DOAJ
language English
format Article
sources DOAJ
author Cristina Grigorescu
Antonela Antoniu Sabina
Ruxandra Oţelea Marina
Antohe Ileana
Petronela Fildan Ariadna
Anton Arghir Ioan
Doina Tofolean Ecaterina
spellingShingle Cristina Grigorescu
Antonela Antoniu Sabina
Ruxandra Oţelea Marina
Antohe Ileana
Petronela Fildan Ariadna
Anton Arghir Ioan
Doina Tofolean Ecaterina
Antivirals for Virus Induced Exacerbations of Asthma and COPD Treatment
ARS Medica Tomitana
antiviral therapy
asthma
copd
oseltamivir
zanamivir
author_facet Cristina Grigorescu
Antonela Antoniu Sabina
Ruxandra Oţelea Marina
Antohe Ileana
Petronela Fildan Ariadna
Anton Arghir Ioan
Doina Tofolean Ecaterina
author_sort Cristina Grigorescu
title Antivirals for Virus Induced Exacerbations of Asthma and COPD Treatment
title_short Antivirals for Virus Induced Exacerbations of Asthma and COPD Treatment
title_full Antivirals for Virus Induced Exacerbations of Asthma and COPD Treatment
title_fullStr Antivirals for Virus Induced Exacerbations of Asthma and COPD Treatment
title_full_unstemmed Antivirals for Virus Induced Exacerbations of Asthma and COPD Treatment
title_sort antivirals for virus induced exacerbations of asthma and copd treatment
publisher Sciendo
series ARS Medica Tomitana
issn 1841-4036
publishDate 2018-11-01
description Viral respiratory infections in patients with asthma or chronic obstructive pulmonary disease (COPD) can cause severe exacerbations, increasing the risk of secondary bacterial infections and having a significant impact on disease-related morbidity and mortality. Several antivirals such as oseltamivir and zanamivir evaluated in influenza and other virus-induced respiratory infections are discussed in this review as a starting point of their potential use in improving the outcome of asthma and COPD exacerbations. However, the efficacy of antiviral therapy for asthma/COPD exacerbations needs a further evaluation.
topic antiviral therapy
asthma
copd
oseltamivir
zanamivir
url https://doi.org/10.2478/arsm-2018-0027
work_keys_str_mv AT cristinagrigorescu antiviralsforvirusinducedexacerbationsofasthmaandcopdtreatment
AT antonelaantoniusabina antiviralsforvirusinducedexacerbationsofasthmaandcopdtreatment
AT ruxandraoteleamarina antiviralsforvirusinducedexacerbationsofasthmaandcopdtreatment
AT antoheileana antiviralsforvirusinducedexacerbationsofasthmaandcopdtreatment
AT petronelafildanariadna antiviralsforvirusinducedexacerbationsofasthmaandcopdtreatment
AT antonarghirioan antiviralsforvirusinducedexacerbationsofasthmaandcopdtreatment
AT doinatofoleanecaterina antiviralsforvirusinducedexacerbationsofasthmaandcopdtreatment
_version_ 1717766578662014976

Similar Items